FIH, Bispecific CD276xCD3 Antibody CC-3 in Patients With Colorectal Cancer | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
FIH, Bispecific CD276xCD3 Antibody CC-3 in Patients With Colorectal Cancer	Digestive System Diseases, Digestive System Neoplasms, Genital Diseases, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Connective and Soft Tissue, Skin and Connective Tissue Diseases, Urogenital Diseases, Urogenital Neoplasms, breast carcinoma, breast disorder, breast neoplasm, colonic disorder, colorectal cancer, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, male reproductive organ cancer, male reproductive system disorder, neoplasm, penile carcinoma, penile disorder, penile neoplasm, rectal disorder, sarcoma, skin disorder	Recruiting	Phase 1	2025-05-21		NCT05999396

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
German Cancer Research Center	47

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
University Hospital Tuebingen	Tübingen	Germany	7